Skip to content

Use of Hair to Diagnose the Presence of Breast Cancer

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00419900
Enrollment
2000
Registered
2007-01-09
Start date
2006-12-31
Completion date
Unknown
Last updated
2007-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, diagnosis, x-ray diffraction, synchrotron, hair

Brief summary

Using synchrotron X-ray diffraction, it has been reported that a hair from an individual with breast cancer exhibits a difference in its molecular structure compared to that of an individual without breast cancer. This difference is visible in the X-ray diffraction pattern as a ring superimposed on the pattern for normal hair. The hypothesis of this study is that synchrotron x-ray diffraction can be used to differentiate hairs from women with medically diagnosed breast cancer from women not known to have the disease. To test this hypothesis, hair from 2000 women attending radiology clinics for mammography will be collected, analysed by x-ray diffraction and then analysed using Fermiscan proprietary image analysis software. The mammogram status of the subjects will be blinded from the diffraction analysts. Results will then be compared with mammography results to allow a direct comparison between the Fermiscan test and mammography in terms of specificity and sensitivity.

Interventions

PROCEDUREdiagnosis of breast cancer by x-ray diffraction of hair

Sponsors

Fermiscan Ltd
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
SINGLE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult women (aged \>20) who are undergoing mammography, and * Who are willing and able to provide informed consent; and * Who have usable scalp and/or pubic hair

Exclusion criteria

* Women who have dyed or permed their scalp hair within the previous 6 weeks and whose pubic hair is unavailable; * Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN \[cervical intra-epithelial neoplasia\]) within 5 years.

Design outcomes

Primary

MeasureTime frame
Accuracy (sensitivity and specificity) of the breast cancer test based on detection of an abnormal pattern of hair x-ray diffraction compared to the gold standard of mammography plus biopsy where indicated

Secondary

MeasureTime frame
The prevalence of a positive hair x-ray diffraction pattern and a negative mammogram; and the prevalence of a negative hair x-ray diffraction pattern and a positive mammogram;

Countries

Australia

Contacts

Primary ContactPeter W French, BSc, MSc, PhD
pfrench@fermiscan.com.au+61292454460
Backup ContactGary Corino, BSc
gcorino@fermiscan.com.au+61292454460

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026